220 related articles for article (PubMed ID: 18975394)
1. Should you go generic?
Carmichael M
Newsweek; 2008 Oct; 152(15):78. PubMed ID: 18975394
[No Abstract] [Full Text] [Related]
2. The generic drug approval process.
Rheinstein PH
Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
[No Abstract] [Full Text] [Related]
3. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
Heller WM
Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
[No Abstract] [Full Text] [Related]
4. NerveCenter: FDA requirements for generic drug applications.
Ann Neurol; 2010 Sep; 68(3):A11. PubMed ID: 20818779
[No Abstract] [Full Text] [Related]
5. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
Hendeles L; Hochhaus G; Kazerounian S
Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
[No Abstract] [Full Text] [Related]
6. Greater access to generic drugs. New FDA initiatives to improve drug reviews and reduce legal loopholes.
Meadows M
FDA Consum; 2003; 37(5):12-7. PubMed ID: 14666900
[No Abstract] [Full Text] [Related]
7. Sandoz sues FDA over delay in first biogeneric approval.
Fox JL
Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046
[No Abstract] [Full Text] [Related]
8. Challenges in the anticipation of biosimilars: how must a P&T committee gear up?
Tadlock C
Manag Care Interface; 2007 Apr; 20(4):12, 14. PubMed ID: 17536251
[No Abstract] [Full Text] [Related]
9. SuperGenerics: a better alternative for biogenerics.
Charles SA
Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591
[No Abstract] [Full Text] [Related]
10. WHO pulls Indian generics off AIDS drugs list.
Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402
[No Abstract] [Full Text] [Related]
11. Current regulatory and legal considerations for follow-on biologics.
Kingham RF; Lietzan E
Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
[No Abstract] [Full Text] [Related]
12. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Jul; 74(143):37163-8. PubMed ID: 19655468
[TBL] [Abstract][Full Text] [Related]
13. Drug wars ahead.
Rosenberg D
Newsweek; 2004 Dec; 144(23):72, 74. PubMed ID: 15605726
[No Abstract] [Full Text] [Related]
14. Multinational medicines--ensuring drug quality in an era of global manufacturing.
Okie S
N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
[No Abstract] [Full Text] [Related]
15. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
16. FDA notifications. FDA: tentative approval of generic nevirapine.
AIDS Alert; 2008 Jul; 23(7):80-1. PubMed ID: 18693339
[No Abstract] [Full Text] [Related]
17. Generic drugs.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 May; (IB61):1-18. PubMed ID: 12807116
[No Abstract] [Full Text] [Related]
18. Generic drugs--safe, effective, and affordable.
Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
[TBL] [Abstract][Full Text] [Related]
19. FDA notifications. Tentative approval for generic stavudine, oral solution.
AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959
[No Abstract] [Full Text] [Related]
20. Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines.
Giaquinta D
Manag Care Interface; 2002 Jun; 15(6):31-4. PubMed ID: 12087604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
